Handelsbanken Fonder AB acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 17,400 shares of the company’s stock, valued at approximately $128,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock worth $169,000 after purchasing an additional 5,767 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in shares of LifeStance Health Group by 10.5% in the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares during the period. Rhumbline Advisers lifted its stake in LifeStance Health Group by 4.5% during the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock worth $1,441,000 after purchasing an additional 8,487 shares during the last quarter. Finally, MetLife Investment Management LLC grew its position in LifeStance Health Group by 14.3% in the third quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock valued at $563,000 after acquiring an additional 10,084 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.
LifeStance Health Group Stock Performance
Shares of LFST opened at $7.91 on Tuesday. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of -30.42 and a beta of 1.28. The stock has a 50 day moving average of $7.81 and a 200 day moving average of $7.26. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $8.61.
Analysts Set New Price Targets
Read Our Latest Report on LFST
LifeStance Health Group Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading
- Five stocks we like better than LifeStance Health Group
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Election Stocks: How Elections Affect the Stock Market
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Most active stocks: Dollar volume vs share volume
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.